SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-068374
Filing Date
2021-03-04
Accepted
2021-03-04 06:06:59
Documents
10
Group Members
MERCK SHARP & DOHME CORP.PANAMA MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D d112314dsc13d.htm SC 13D 115038
2 EX-99.2 d112314dex992.htm EX-99.2 22867
3 EX-99.3 d112314dex993.htm EX-99.3 12224
4 EX-99.4 d112314dex994.htm EX-99.4 15802
5 EX-99.5 d112314dex995.htm EX-99.5 14376
6 EX-99.6 d112314dex996.htm EX-99.6 24879
7 EX-99.7 d112314dex997.htm EX-99.7 6203
8 GRAPHIC g112314g00q65.jpg GRAPHIC 2840
9 GRAPHIC g112314g36v08.jpg GRAPHIC 3356
10 GRAPHIC g112314sp1.jpg GRAPHIC 8858
  Complete submission text file 0001193125-21-068374.txt   229095
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Subject) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91578 | Film No.: 21712465
SIC: 2834 Pharmaceutical Preparations